IRIDEX CFO buys 2,354 shares at $0.65
IRIDEX’s chief financial officer increased his personal IRIX shareholdings through a small open-market purchase.
Rhea-AI Filing Summary
IRIDEX CORP (IRIX) reported that its Chief Financial Officer, Romeo R. Dizon, purchased 2,354 shares of common stock on September 14, 2026 at $0.65 per share in an open-market or private transaction. Following this buy, he directly holds 177,406 shares of IRIDEX common stock. No Rule 10b5-1 trading plan is reported for this transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 2,354 shares
Net Buy
1 txn
Insider
Dizon Romeo R
Role
Chief Financial Officer
Bought
2,354 shs ($2K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 2,354 | $0.65 | $2K |
Holdings After Transaction:
Common Stock — 177,406 shares (Direct)
Key Figures
Shares purchased: 2,354 shares
Purchase price per share: $0.65 per share
Shares owned after transaction: 177,406 shares
3 metrics
Shares purchased
2,354 shares
Common stock bought by the CFO on September 14, 2026
Purchase price per share
$0.65 per share
Price paid by the CFO for IRIDEX common stock
Shares owned after transaction
177,406 shares
Direct holdings of the CFO following the reported purchase
Key Terms
Rule 10b5-1, open-market, Form 4
3 terms
Rule 10b5-1 regulatory
"No Rule 10b5-1 trading plan is reported for this transaction"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
open-market market
"Purchase in open market or private transaction"
Open-market describes trading that happens in a public marketplace where many buyers and sellers can freely buy and sell securities or assets, like stocks or bonds, rather than through a private agreement. It matters to investors because prices in an open market reflect real-time supply and demand, making it easier to buy or sell quickly and to gauge fair market value — like checking a public price board instead of negotiating one-on-one.
Form 4 regulatory
"The Form 4 for IRIDEX CORP shows a purchase"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did IRIX report for its CFO?
IRIDEX CORP reported that Chief Financial Officer Romeo R. Dizon bought 2,354 shares of common stock on September 14, 2026 in an open-market or private transaction at $0.65 per share.
Was the IRIX CFO’s September 14, 2026 trade under a Rule 10b5-1 plan?
No. The filing indicates no Rule 10b5-1 trading plan for the September 14, 2026 purchase by IRIDEX CORP’s Chief Financial Officer.
Was the IRIX CFO’s Form 4 transaction a purchase or a sale?
The Form 4 for IRIDEX CORP shows a purchase by the Chief Financial Officer, involving 2,354 shares of common stock at $0.65 per share on September 14, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.